A rationale for monoamine oxidase inhibition as neuroprotective therapy for parkinson's disease

1993 ◽  
Vol 8 (S1) ◽  
pp. S1-S7 ◽  
Author(s):  
C. W. Olanow
1989 ◽  
Vol 46 (5) ◽  
pp. 528-536 ◽  
Author(s):  
Rainer Schulz ◽  
Karl-Heinz Antonin ◽  
Edgar Hoffmann ◽  
Maria Jedrychowski ◽  
Eric Nilsson ◽  
...  

2016 ◽  
Vol 14 (2) ◽  
pp. 163-165 ◽  
Author(s):  
Hamlin Emory ◽  
Neptune Mizrahi

We present clinical, electroencephalographic and low-resolution electromagnetic tomography data that support combined treatment with insulin and a monoamine oxidase inhibitor in a patient with type 1 diabetes. We suggest that brain imaging data can identify a subgroup of patients who are likely to benefit from an insulin regimen and monoamine oxidase inhibition to improve glycaemic control, cardiovascular function, normalize the circadian rhythm and restore perception of glycaemic awareness.


2017 ◽  
Vol 42 (11) ◽  
pp. 3289-3295 ◽  
Author(s):  
David S. Goldstein ◽  
Yunden Jinsmaa ◽  
Patti Sullivan ◽  
Yehonatan Sharabi

2009 ◽  
Vol 34 (8) ◽  
pp. 1427-1432 ◽  
Author(s):  
Maroof Husain ◽  
Rakesh Shukla ◽  
Madhu Dikshit ◽  
Pradeep K. Maheshwari ◽  
Devika Nag ◽  
...  

2016 ◽  
Vol 41 (9) ◽  
pp. 2173-2178 ◽  
Author(s):  
David S. Goldstein ◽  
Yunden Jinsmaa ◽  
Patti Sullivan ◽  
Courtney Holmes ◽  
Irwin J. Kopin ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document